[HTML][HTML] Hedgehog signaling and truncated GLI1 in cancer
D Doheny, SG Manore, GL Wong, HW Lo - Cells, 2020 - mdpi.com
The hedgehog (HH) signaling pathway regulates normal cell growth and differentiation. As a
consequence of improper control, aberrant HH signaling results in tumorigenesis and …
consequence of improper control, aberrant HH signaling results in tumorigenesis and …
Epigenomics of leukemia: from mechanisms to therapeutic applications
C Florean, M Schnekenburger, C Grandjenette… - …, 2011 - Future Medicine
Leukemogenesis is a multistep process in which successive transformational events
enhance the ability of a clonal population arising from hematopoietic progenitor cells to …
enhance the ability of a clonal population arising from hematopoietic progenitor cells to …
The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells
K Rothe, H Lin, KBL Lin, A Leung… - Blood, The Journal …, 2014 - ashpublications.org
Previous studies demonstrated that imatinib mesylate (IM) induces autophagy in chronic
myeloid leukemia (CML) and that this process is critical to cell survival upon therapy …
myeloid leukemia (CML) and that this process is critical to cell survival upon therapy …
A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA
Aberrant expression of long noncoding RNAs (lncRNAs) is associated with various human
cancers. However, the role of lncRNAs in Bcr-Abl-mediated chronic myeloid leukemia (CML) …
cancers. However, the role of lncRNAs in Bcr-Abl-mediated chronic myeloid leukemia (CML) …
Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia
BM Barth, E I. Altinoğlu, SS Shanmugavelandy… - ACS …, 2011 - ACS Publications
Leukemia is one of the most common and aggressive adult cancers, as well as the most
prevalent childhood cancer. Leukemia is a cancer of the hematological system and can be …
prevalent childhood cancer. Leukemia is a cancer of the hematological system and can be …
[HTML][HTML] Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
S Corrêa, R Binato, B Du Rocher, MTL Castelo-Branco… - BMC cancer, 2012 - Springer
Background The advanced phases of chronic myeloid leukemia (CML) are known to be
more resistant to therapy. This resistance has been associated with the overexpression of …
more resistant to therapy. This resistance has been associated with the overexpression of …
[HTML][HTML] Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
M Massimino, S Stella, E Tirrò, C Romano, MS Pennisi… - Molecular cancer, 2018 - Springer
The introduction of ABL Tyrosine Kinase Inhibitors (TKIs) has significantly improved the
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
outcome of Chronic Myeloid Leukemia (CML) patients that, in large part, achieve satisfactory …
targeting Primitive chronic Myeloid leukemia cells by effective inhibition of a New AHi-1–Bcr-ABl–JAK2 complex
M Chen, P Gallipoli, D DeGeer, I Sloma… - Journal of the …, 2013 - academic.oup.com
Background Imatinib mesylate (IM) induces clinical remission of chronic myeloid leukemia
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …
(CML). The Abelson helper integration site 1 (AHI-1) oncoprotein interacts with BCR-ABL …
[HTML][HTML] Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level
In more recent years, a significant increase in the number of available biological
experiments has taken place due to the widespread use of massive sequencing data …
experiments has taken place due to the widespread use of massive sequencing data …
[HTML][HTML] Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21
Z Li, L Yang, X Liu, Z Nie, J Luo - Biomedicine & Pharmacotherapy, 2018 - Elsevier
The long noncoding RNA (lnc) maternally expressed 3 (MEG3) is downregulated in many
types of cancers. However, the relationship between lncRNA MEG3, microRNA-21 (miR-21) …
types of cancers. However, the relationship between lncRNA MEG3, microRNA-21 (miR-21) …